Ovarian Cancer News

OCRF- Super Luncheons

2009-09-01T12:08:00.001-04:00

September is ovarian cancer awareness month. To mark the occasion, the Ovarian Cancer Research Fund will host lunches at Governors' mansions and designated event spaces throughout the nation. First Ladies and Governors will participate in the Super Luncheon program. As our distinguished guest, you will hear a leading oncologist speak, meet those battling the disease, ovarian cancer survivors, community leaders, and other supporters like yourself.

2nd Annual " Teal Tuesday" September 15th, 2009

2009-09-01T11:36:00.002-04:00

2nd Annual " Teal Tuesday" 3rd Tuesday of September.
THINK TEAL, TALK TEAL, WEAR TEAL ~ SAVE LIVES. Tuesday, September 15th, 2009. "NATIONAL OVARIAN CANCER AWARENESS DAY".

TEAL POWER! Be a soldier in this war against Gynecologic Cancers.Please take a stand, assemble together in a TEAL UNION FOR THE GREATER GOOD!

Teal Toes- Raising Ovarian Cancer Awareness

2009-09-01T11:02:00.000-04:00

Loehmann's Fashion Funds Hope- Ovarian Cancer Research Fund

2009-09-01T10:59:00.000-04:00

Loehmann's Fashion Funds Hope

September 24, 2009 Fashion Funds Hope

L'Oreal Ovarian Cancer Awareness Week

2009-09-01T10:55:00.000-04:00

L'Oreal Ovarian Cancer Awareness Week

September 14 - 20, 2009

Color Of Hope

NYTW Presents " I got Sick Then Got Better"

2009-09-01T10:49:00.000-04:00

NYTW Presents" I GOT SICK THEN I GOT BETTER" Written and performed by Jenny Allen Directed by James Lapine & Darren Katz
Photo by Jayne Wexler
Limited EngagementStarting September 14, 2009 for four consecutive Mondays only.Special Benefit Opening Nightfor The Ovarian Cancer Research Fund more information

"I Got Sick Then I Got Better" is a wrenching comic riff on one woman's adventures after falling down the medical rabbit hole. Diagnosed with andtreated for ovarian cancer in 2005, writer and performer Jenny Allen (The New Yorker, The New York Times) tells her story of the harrowing tailspin she took following her diagnosis, combining biting humor with searing emotion in a witty, bittersweet monologue that limns the personal and family collateral damage a life-threatening illness brings.

September 26, 2009 Fashion Fights Ovarian Cancer_ Sandy Rollman

2009-09-01T10:15:00.000-04:00

Sandy Rollman ~September 26, 2009 Fashion Fights Ovarian CancerDinner, live and silent auction and fashions by top designer Pamela Dennis. Sponsored by Carlino’s; Shops at Liberty Place; 1625 Chestnut St. Philadelphia, PA 19103. 7 PM. Honoring George Coukos, MD, PhD, Associate Chief, Division of Gynecologic Oncology Director, Ovarian Cancer Research Center University of Pennsylvania with the Angela Carlino Excellence in Ovarian Cancer Research/Care Award.The Premiere of an Official Ovarian Cancer T-shirt designed by Pamela Dennis.

Teal Walk- September 12th, 2009 Prospect Park, Brooklyn, NY

2009-09-01T09:54:00.000-04:00

Saturday, September 12, 2009
Prospect Park, Brooklyn, New York

A non-competitive 5K event.

September is National Ovarian Cancer awareness month.

Please join us on Saturday, September 12, 2009 for Tell Every Amazing Lady About Ovarian Cancer’s first annual T.E.A.L. Walk in Brooklyn’s Prospect Park. Bring all of your friends and family members and help us make a difference! All proceeds from this year’s T.E.A.L. Walk will be donated to The Ovarian Cancer Research Fund (OCRF)

OCRF~ GET INVOLVED NOW and we'll donate 22,000

2009-09-01T08:40:00.001-04:00

On September 1, 2009, join Seventh Generation to save women's lives. For every person that registers, $1 will be donated to the OCRF until we hit $22,000 (each year 22,000 women are diagnosed with the disease).

Join us at our 3rd Annual 3 K Walk to "Break the Silence" for Ovarian Cancer

2009-09-01T06:38:00.000-04:00

Don't miss being part of the biggest Ovarian Cancer Day on LI it's just 25 days away.........

Join us at our 3rd Annual 3 K Walk to "Break the Silence" for Ovarian Cancer

September 26, 2009
Eisenhower Park- Field 5, East Meadow NY

Please see the attached PDF for your convenience.
If you prefer please visit our walk page at:

http://nocc.kintera.org/nyli

We ask you to forward this email to your family / friends / Co-workers. If you have any questions or concerns about this day please do not hesitate to contact us at 631-672-2027 or nyli.nocc@ovarian.org
Liz Pittelko
President

Long Island ChapterNational Ovarian Cancer Coalition
PO Box 20666
Huntington Station, NY 11746631-672-2027
nyli.nocc@ovarian.org
www.ovarian.org

50 x 50 Campaign ~ September 20, 2009

2009-08-31T12:03:00.000-04:00

See Jenn Tri to raise $100,000 by competing in triathlons in all 50 states by the age of 50.

Perceived Cancer Risks May Not Show Actual Risks Or Prevention Needs

2009-05-16T16:07:00.000-04:00

Ovarian cancer From Wikipedia, the free encyclopedia

2009-05-16T16:01:00.001-04:00

Epidemiological and Genetic Factors Associated With Ovarian Cancer.

2009-05-16T15:57:00.001-04:00

Activated platelets enhance ovarian cancer cell invasion in a cellular model of metastasis.

2009-05-16T15:56:00.003-04:00

A Phase I/II Study of Docetaxel and Gemcitabine Combination for Chemotherapy-resistant Ovarian Cancer.

2009-05-16T15:56:00.001-04:00

Ovarian serous adenocarcinoma identified during IVF: diagnostic approach, surgical management, and reproductive outcome.

2009-05-16T15:55:00.003-04:00

Understanding the functions of BRCA1 in the DNA-damage response.

2009-05-16T15:55:00.001-04:00

Drug That Targets Vasculature Growth Attacks Aggressive Thyroid Cancer

2009-05-16T15:53:00.000-04:00

Many People Misjudge Their Degree Of Cancer Risk

2009-05-16T15:52:00.000-04:00

A new weapon in the fight against ovarian cancer may soon help thousands of women who have run out of options.

2009-05-16T09:05:00.000-04:00

Drug ruling a victory for cancer patients

2009-05-16T08:56:00.000-04:00

Cancer Patients Challenge the Patenting of a Gene

2009-05-13T22:20:00.000-04:00

Stand Up For Health Care | A project of Families USA

2009-05-05T12:25:00.000-04:00

Stand Up For Health Care A project of Families USA

2009 GCF Ovarian Cancer Survivors Course

2009-05-05T12:20:00.001-04:00

If ever there was a time to be in Washington, D.C, it's NOW!

2009-05-04T09:55:00.003-04:00

The 12th annual Ovarian Cancer National Alliance

“Celebration of Life” Conference

July 6th- 9th, 2009

Omni Shoreham Hotel in Washington, D.C.

Ovarian Cancer Biomarker Research Act

2009-05-04T09:42:00.003-04:00

Ovarian Cancer Biomarker Bill Will be Introduced in the House of Representatives

Ovarian Cancer Biomarker Research ActBill # S.2569

Original Sponsor:Barbara Boxer (D-CA)Cosponsor Total: 16(last sponsor added 06/23/2008) 14 Democrats 1 Independents 1 Republicans

About This Legislation:A bill to amend the Public Health Service Act to authorize the Director of the National Cancer Institute to make grants for the discovery and validation of biomarkers for use in risk stratification for, and the early detection and screening of, ovarian cancer.

Urge your Representative to Sign On to H.R. 1230

2009-05-04T09:29:00.002-04:00

Grassroots Action Center

Urge your Representative to Sign On to H.R. 1230

On February 26, 2009, Representative Doris O. Matsui (D-CA) formally introduced the Bone Marrow Failure Disease Research and Treatment Act of 2009 (H.R. 1230). This legislation would bring together the resources of several federal agencies to advance our understanding of and treatments for aplastic anemia, myelodysplastic syndromes, and PNH. We need your support now

aWEARness- giving voice to the whispers

2009-05-02T20:15:00.003-04:00

Drug combo helps with repeat cancers in women

2009-05-01T23:41:00.000-04:00

Jon Lovitz Supports OCRF With New Comedy Club Opening

2009-05-01T05:35:00.000-04:00

Lovitz will perform opening night at The Jon Lovitz Comedy Club, located on CityWalk at Universal Studios Hollywood. The club features a Hawaiian beach motif, complete with sand dunes, palm trees, and delicious food for club-goers, and boasts a three-story, 400 seat capacity in which to enjoy live music and stand-up comedy.

A long-time friend of Faith Kates Kogan, president of OCRF's Board of Directors and founder of NEXT Model Management, Lovitz has participated in several of OCRF's signature events throughout the years, including Super Saturday LA. NEXT Model Management will co-host the gala benefit.

"It feels good to be able to do something like that," Lovitz says of his support for OCRF. Referencing Gilda Radner and Madeline Kahn, he recognizes that many great women in comedy have been taken too soon from cancer. "The whole point is to raise money for a cure and also for early detection."

OCRF thanks Jon Lovitz for his ongoing support, and for all that he has done to spread awareness and raise funds to continue the progression of ovarian cancer research. We wish him the best of luck in his endeavor, and encourage everyone to stop by the club to enjoy a great night of entertainment.

6th Annual Marie S. Franck " Footsteps toward Hope Ovarian Cancer Walk"

2009-04-18T07:45:00.001-04:00

You can make a difference in the fight against ovarian cancer. Walk in memory or walk for a survivor at the 6th annual Marie S. Franck Foosteps Toward Hope Ovarian Cancer Walk on May 2, 2009 at 8:30am at the Jones Beach Boardwalk, parking field #5.

All proceeds will benefit the Rosewell Park Cancer Institute in Buffalo. Help them break the $100,000 mark with this year's donations!

To sign up, call Sister Suzanne at St. Joseph's College in Patchogue at (631) 447-6581.

March 26th, 2009 Loehmann's Fashion Funs Hope to benefit the OCRF-Ovarian Cancer Research Fund

2009-03-16T12:34:00.001-04:00

On Thursday, March 26th, fashion-savvy, budget-minded shoppers can support Ovarian cancer research while receiving special savings on leading designer apparel for one day only, at any of the sixty-four Loehmann's stores across the country.

As part of its chain-wide Fashion Funds Hope in-store event, Loehmann's will offer an additional 15% discount above its standard 30-65% savings to any customer who donates five dollars to the Ovarian Cancer Research Fund (OCRF).

In addition, Loehmann's will make a contribution to OCRF of 5% of total purchases by donors.Loehmann's customers will be able to pick up information about ovarian cancer, from risk factors and symptoms to the three programs run by OCRF, at tables set up inside the stores that day.

Doo- Wop Concert for Ovarian Cancer

2009-03-16T11:31:00.000-04:00

March 26th, 2009 Loehmann's Store's host Fasion Funds Hope to benefit the OCRF

2009-03-12T12:29:00.000-04:00

OCRF is pleased to announce that on March 26, Loehmann’s stores will host Fashion Funds Hope, a fun-filled day of shopping and savings to benefit the Ovarian Cancer Research Fund.

We invite you to help make this day a success by volunteering to represent OCRF at a Loehmann’s store location near you.

As a volunteer, you can help disseminate OCRF literature and encourage shoppers to donate in support of life-saving ovarian cancer research. Participate in Fashion Funds Hope, and organize a team of family and friends to help raise funds and awareness for ovarian cancer. With your help, we will make this day a nationwide success!

THE SANDY SPRINT- 5K April 25th, 2009

2009-03-10T22:56:00.000-04:00

SASS FOUNDATION -April 4th, 2009 -Ovarian Cancer Awareness Day at the East Wind Inn & Spa

2009-03-10T12:15:00.000-04:00

TEAL TOES

2009-03-09T22:00:00.000-04:00

CAMP MAK-A-DREAM ~OVARIAN CANCER RETREATS

2009-03-01T21:52:00.000-05:00

Is stress a risk factor for cancer?

2009-02-19T18:29:00.002-05:00

Upcoming Lecture " Advances in Gyn Oncology" given by Dr. Jeanine Villella

2009-02-16T17:14:00.000-05:00

Dr. Jeannine Villella, Attending Physician, Division of Gyn Oncology at Winthrop University Hospital will be giving an evening lecture to the community on March 12, 2009 on the topic “Advances in Gyn Oncology.”

If interested in attending please contact : Julie Mischo RN, MSNCancer Care Coordinator
Winthrop University Hospital

Phone 516-663-4637

Women's cancer outcomes improved by surgical evaluation

2009-02-12T23:36:00.000-05:00

Vascular Experts Call for Increased Awareness of Growing Problem of Lymphedema

2009-02-12T15:36:00.002-05:00

Committee approves bill on ovarian cancer awareness

2009-02-12T15:36:00.001-05:00

Ovarian cancer: The search for an accurate screening technique

2009-02-12T15:31:00.001-05:00

Women's cancer outcomes improved by surgical evaluation

2009-02-12T15:28:00.000-05:00

SGO: Few Ovarian Cancer Patients Tolerate Intraperitoneal Regimen

2009-02-12T15:24:00.001-05:00

OCRF and GCF fund new ovarian cancer symptoms study

2009-02-12T15:09:00.001-05:00

OCRF and GCF fund new ovarian cancer symptoms study

Study hopes to improve symptom recognition

New York (February 5, 2009) --- Today, the Ovarian Cancer Research Fund (OCRF), in partnership with the Gynecologic Cancer Foundation (GCF), announced that Barbara Goff, M.D., Director of Gynecologic Oncology at the University of Washington, has been named to lead the OCRF Ovarian Cancer Symptoms Study. The award was presented by OCRF Scientific Advisory Board Vice-Chair, Carmel Cohen, M.D., at the Society of Gynecologic Oncologists 40th Annual Meeting on Women's Cancer™ in San Antonio, Texas.

The study builds on an original symptoms study conducted by Dr. Goff which formed the basis for the first national Consensus Statement on Ovarian Cancer Symptoms, issued in 2007. The grant will allow researchers to forge ahead in their efforts to develop a systematic symptoms screening process for ovarian cancer.

Dr. Goff, a leading expert in gynecologic cancer research, was chosen to receive the grant, which will be awarded over three years. She was selected by a committee assembled by the GCF and chaired by Thomas Herzog, M.D. The selection committee also included three members of the OCRF Scientific Advisory Committee.

Prior to the development of the Consensus Statement on Ovarian Cancer Symptoms, ovarian cancer was often referred to as the "silent killer." Dr. Goff's research led to an evidence-based list of symptoms associated with ovarian cancer. When ovarian cancer, the deadliest reproductive cancer, is detected early, it is 90% curable The three-year symptoms study will pilot a method of systematically collecting symptom information with the hope that a symptoms index can be developed for broad use in early ovarian cancer detection.

Dr. Cohen is Professor of Obstetrics and Gynecology at Mount Sinai Medical Center in New York City. "Based on early data, patients with seemingly early disease are included among those who present with new and otherwise unexplained symptoms," Dr. Cohen noted. "While this may not be typical of early ovarian cancer, attention to the symptom complex may still serve as 'early detection' and thereby allow better opportunity for disease control in a segment of the population who develop ovarian cancer. We look forward to the possibility that this study will answer this question."

Dr. Goff has spent years researching and writing about ovarian cancer and the discovery of an early detection method. A diagnostic tool for early detection is crucial since there is a significant difference in cure rates if ovarian cancer is found early. "Through the continuation of this vital research, we aim to debunk the myth that ovarian cancer is a 'silent disease,' and empower both physicians and women to be better equipped to recognize symptoms in their earliest stage," Dr. Goff said. "Huge progress has been made, and now it's time to take the next step."

###
The Ovarian Cancer Research Fund is a 501(c) 3 not-for-profit organization founded in 1994 with a mission to fund research to find a method of early detection and ultimately a cure for ovarian cancer. OCRF is the leading independent agency dedicated to advancing ovarian cancer research in the United States. For more information, visit www.ocrf.org.

The Gynecologic Cancer Foundation (GCF), founded by the Society of Gynecologic Oncologists in 1991, is a 501(c) 3 not-for-profit organization whose mission is to ensure public awareness of gynecologic cancer prevention, early diagnosis and proper treatment. In addition, the Foundation supports research and training related to gynecologic cancers. GCF advances this mission by increasing public and private funds that aid in the development and implementation of programs to meet these goals.

SEND A VIRTUAL CUPCAKE- Electrolux will donate $1.00 to help fight Ovarian Cancer

2009-02-09T23:04:00.000-05:00

This Valentine’s Day when you send a virtual cupcake, Electrolux will donate $1 to help fight ovarian cancer.

Angiogenesis linked to poor survival in patients with rare type of ovarian cancer

2009-02-09T18:35:00.000-05:00

Chef Laurey Masterton is a 20 year survivor of Ovarian Cancer.

2009-02-03T18:25:00.000-05:00

Sixth International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

2009-01-27T17:20:00.000-05:00

Sixth International Symposium on Ovarian Cancer and Other Gynecologic Malignancies

The Ritz-Carlton New York, Battery ParkNew York, NYMar 20-21, 2009

Ovarian Cancer Researchers At Yale Win Millions In Federal And Foundation Grants

2009-01-24T03:34:00.001-05:00

Sood Makes Breakthrough in Ovarian Cancer Research

2009-01-24T03:31:00.001-05:00

HOUSTON, TX - In a major breakthrough, which can dramatically increase survival chances of ovarian cancer patients, an Indian American scientist has identified two proteins whose presence increases the median survival rate by 11 years in patients with the disease.

A study of nearly 250 ovarian cancer patients by Dr Anil Sood, MD, Professor in the departments of Gynecologic Oncology and Cancer Biology at M D Anderson, along with other researchers, found that woman with high levels of two proteins named Dicer and Drosha in their tumor cells had a median survival rate of 11 years. While, in patients with low levels of one or both proteins about 40 percent of those studied had a median survival of less than three years.

Sood’s discovery marks a significant advance for an emerging area of basic science called RNA interference, which one day may transform medicine.

“What’s important is that Dicer and Drosha are critical to the process of RNA interference,” Anil Sood said.

read more: http://www.indiajournal.com/pages/event.php?id=5786

NCI- Animation/Video on Proteomics

2009-01-16T21:49:00.001-05:00

Long Island Press Cover Story- " Disappearing Doctors"

2009-01-16T21:49:00.000-05:00

Force upcoming " Chat-a-thon" Jan 29 th-Jan 31st

2009-01-16T19:50:00.000-05:00

Date: January 29-January 31, 2009
Time : One minute after midnight on January 29 to one minute before midnight on January 31.
Location: The FORCE Chat Room
Check out our regular scheduled chats and come back on the 29th!
Visit our chat room now

CancerCare-Medical Update on Ovarian Cancer- February 26, 2009

2009-01-16T19:09:00.000-05:00

Medical Update on Ovarian Cancer
Thursday, February 26, 2008
1:30 - 2:30 p.m.

This is a free Telephone Education Workshop for women living with ovarian
cancer, their families, friends and health care professionals provided by
CancerCare Connect where leading experts in oncology provide the most up
to date information over the telephone. Speakers for this workshop include
Carolyn D. Runowicz, MD, Ilana Cass, MD, and Patricia Spicer, MSW.

Workshop Topics:
Overview of Ovarian Cancer
Staging
Current Standard of Care
New Treatment Approaches
The Important Role of Clinical Trials
Controlling Symptoms and Pain
Communicating with Your Health Care Team
Quality-of-Life Concerns
Questions and Answers

How to register:
Call CancerCare at 1-800-813-HOPE(4673)
or
on-line using the following link: Medical Update on Ovarian Cancer

Juliana Marchesano, BSW, MPH Intern
Ovarian Cancer Program
NYSDOH Cancer Services Program
(518) 402-9065

Women's Cancer Network- Cancer Risk Assessment Survey

2009-01-15T23:30:00.001-05:00

NCCN Receives $4 Million Oncology Research Grant from Wyeth

2009-01-15T23:23:00.001-05:00

Kathy Bates reveals her triumph over ovarian cancer

2009-01-15T23:21:00.001-05:00

Obesity may raise risk of ovarian cancer

2009-01-15T23:20:00.003-05:00

.Big Health Insurer Agrees to Update Its Fee Data

2009-01-15T23:20:00.001-05:00

Health insurer accused of overcharging millions

2009-01-15T23:19:00.003-05:00

Biotech Firm's Tests Detect Predisposition To Cancer

2009-01-15T23:19:00.001-05:00

Elevation of seprase expression and promotion of an invasive phenotype by collagenous matrices in ovarian tumor cells.

2009-01-15T23:15:00.001-05:00

"Malignant" uterine perivascular epithelioid cell tumor, pelvic lymph node lymphangioleiomyomatosis, and gynecological pecomatosis in a patient with t

2009-01-15T23:13:00.001-05:00

Clinical significance of circulating tumor cells detected by an invasion assay in peripheral blood of patients with ovarian cancer.

2009-01-15T23:12:00.000-05:00

Dicer, Drosha, and outcomes in patients with ovarian cancer.

2009-01-15T23:09:00.000-05:00

Functional significance of VEGFR-2 on ovarian cancer cells.

2009-01-15T23:08:00.001-05:00

Identification of novel peptide ligands for the cancer-specific receptor mutation EFGRvIII using a mixture-based synthetic combinatorial library.

2009-01-15T23:05:00.002-05:00

Nelfinavir induces the unfolded protein response in ovarian cancer cells, resulting in ER vacuolization, cell cycle retardation and apoptosis.

2009-01-15T23:05:00.001-05:00

14-3-3 zeta protein secreted by tumor associated monocytes/macrophages from ascites of epithelial ovarian cancer patients.

2009-01-15T23:04:00.001-05:00

Ovarian carcinoma as a surrogate tumor for lung adenocarcinomas in evaluating the chemo-stability of a gene expression signature.

2009-01-15T23:03:00.001-05:00

A limited panel of immunomarkers can reliably distinguish between clear cell and high-grade serous carcinoma of the ovary.

2009-01-15T23:02:00.001-05:00

Immunohistochemistry, glycosylation and immunosuppression of glycodelin in human ovarian cancer

2009-01-15T23:01:00.000-05:00

Inhibition of multi-drug resistance of ovarian carcinoma by small interfering RNA targeting to MRP2 gene.

2009-01-15T23:00:00.008-05:00

Ovarian carcinoma as a surrogate tumor for lung adenocarcinomas in evaluating the chemo-stability of a gene expression signature.

2009-01-15T23:00:00.001-05:00

Preclinical assessment of anti-cancer drugs by using RP215 monoclonal antibody.

2009-01-15T22:59:00.001-05:00

Chromosomes 6 and 18 induce neoplastic suppression in epithelial ovarian cancer cells.

2009-01-15T22:58:00.001-05:00

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers.

2009-01-15T22:57:00.003-05:00

Tamoxifen prevents premalignant changes of breast, but not ovarian, cancer in rats at high risk for both diseases.

2009-01-15T22:57:00.001-05:00

Time to stop ovarian cancer screening in BRCA1/2 mutation carriers?

2009-01-15T22:56:00.001-05:00

A prospective study of quality of life among women undergoing risk-reducing salpingo-oophorectomy versus gynecologic screening for ovarian cancer.

2009-01-15T22:55:00.001-05:00

Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer.

2009-01-15T22:54:00.003-05:00

Functional significance of VEGFR-2 on ovarian cancer cells.

2009-01-15T22:54:00.001-05:00

The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer.

2009-01-15T22:53:00.001-05:00

Ovarian carcinoma subtypes are different diseases: implications for biomarker studies.

2009-01-15T22:52:00.001-05:00

IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype.

2009-01-15T22:51:00.001-05:00

A proteomic approach to paclitaxel chemoresistance in ovarian cancer cell lines.

2009-01-15T22:48:00.001-05:00

Enhanced complement resistance in drug-selected P-glycoprotein expressing multi-drug-resistant ovarian carcinoma cells.

2009-01-15T22:47:00.001-05:00

YKL-40 tissue expression andplasma levels in patients with ovarian cancer.

2009-01-15T22:42:00.000-05:00

Oregovomab Maintenance Monoimmunotherapy Does Not Improve Outcomes in Advanced Ovarian Cancer

2009-01-15T22:41:00.001-05:00

Cancer: The Road to Amiens

2009-01-15T22:40:00.001-05:00

An Indomitable Spirit Gets Help With Medical Benefits

2009-01-15T22:37:00.000-05:00

Enhancing the efficacy of cisplatin in ovarian cancer treatment - could arsenic have a role

2009-01-15T22:34:00.001-05:00

'Normal lifespan' is goal in ovarian cancer screening study, Ian Jacobs tells HOW group

2009-01-15T22:33:00.001-05:00

Stem Cells Could Be Used For Personalized Cancer Treatment

2009-01-15T22:19:00.001-05:00

Anticipation in Lynch Syndrome: Still Waiting for the Answer

2009-01-15T22:15:00.001-05:00

Insurers Accused Of Underpaying Patients. CBS Evening News: New York AG Investigates Whether Health Care Companies Perpetuated Fraud

2009-01-14T21:42:00.001-05:00

http://www.cbsnews.com/video/watch/?id=4720000n